Advertisement
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Advertisement
You have accessJournal of UrologyCME1 Apr 2023

MP03-02 ASSESSMENT OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 VIA M2 MACROPHAGE-SEEDED COLLAGEN MESH FOR TREATMENT OF STRESS URINARY INCONTENCE

    View All Author Information

    INTRODUCTION AND OBJECTIVE:

    Over the past decade, there have been several innovations with respect to macrophage-based therapies and biomaterials. Patients suffering from stress urinary incontinence (SUI) exhibit a significant increase in matrix metalloproteinase-9 (MMP-9) and a significant decrease in tissue inhibitor of metalloproteinase-1 (TIMP-1) expression. These findings are consistent with elevated rates of collagen breakdown and may play a critical role in the onset and development of SUI. Our recent study demonstrated improved biomechanical and histological outcomes following incorporation of M2 macrophages into a collagen mesh developed for tissue repair and offers future strategies focused on connective tissue regeneration. This study aims to assess the regulation of MMP-9 and TIMP-1 by M2 macrophages in terms of regenerating connective tissue in a rat model.

    METHODS:

    Macrophages were harvested from rat bone marrow, and macrophage subtypes were identified by flow cytometry. Electrochemically aligned collagen threads were filament wound to produce small collagen meshes and seeded with macrophages and cultured for up to 3 days. Macrophage subtype-seeded meshes were implanted subcutaneously in rats and harvested at 3 weeks and 3 months, respectively. Explanted meshes were analyzed using histology and immunohistochemistry. Specimens stained separately for MMP-9 and TIMP-1, and quantified to determine overall presence of MMP-9 and TIMP-1 in the harvested tissues.

    RESULTS:

    Immunohistochemical staining demonstrated a reduction of MMP-9 with addition of M2 macrophages, whereas the M1-seeded group continued to exhibit elevated MMP-9 after 3 months. TIMP-1 presence was elevated with the addition of M2 macrophages, whereas the M1-seeded group showed low TIMP-1 after 3 months (Figure 1).

    CONCLUSIONS:

    Delivery of M2 macrophages via collagen mesh can reduce MMP-9 while increasing TIMP-1, which may limit collagen breakdown associated with the development of SUI. This study shows the potential for improved restoration of extracellular matrix following the incorporation of M2 macrophages into a genipin-crosslinked collagen mesh for tissue repair and remodeling.

    Download PPT

    Source of Funding:

    NIH grant: R21HD095439